
VentureMed Group is a pioneering privately held medical device company based in Minnesota dedicated to advancing endovascular solutions for arteriovenous access and peripheral arterial disease interventions. The company's flagship technology, the FLEX Vessel Prep System, is an FDA 510k-cleared and CE Mark-approved device, that is designed to optimize vessel preparation using its proprietary Kinetic Endovascular Micro-incision Creation technology. Unlike traditional balloon-based approaches that apply static pressure, KEMIC leverages controlled motion and dynamic vessel apposition to create long, precise micro-incisions. This unique mechanism facilitates luminal gain, may enhance drug uptake when used in combination therapy, and may reduce vessel trauma - ultimately lowering the risk of restenosis
| Date | Amount | Type | Investors | Valuation | 
|---|---|---|---|---|
| 10/29/25 | $28,000,000 | Series C | Endeavor Vision S3 Ventures  | undisclosed |